India · Delayed Price · Currency is INR Verve Therapeutics Statistics
Total Valuation
BOM:543913 has a market cap or net worth of INR 227.69 billion. The enterprise value is 269.72 billion.
| Market Cap | 227.69B |
| Enterprise Value | 269.72B |
Important Dates
The last earnings date was Wednesday, July 30, 2025.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | Aug 4, 2025 |
Share Statistics
| Current Share Class | 1.52B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.06% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 49.20 and the forward PE ratio is 32.50.
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | 49.20 |
| Forward PE | 32.50 |
| PS Ratio | 9.41 |
| PB Ratio | 1.61 |
| P/TBV Ratio | 2.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 58.28 |
| EV / Sales | 11.15 |
| EV / EBITDA | 16.14 |
| EV / EBIT | 24.86 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 3.19 |
| Debt / FCF | n/a |
| Interest Coverage | 2.61 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 3.52% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 42.30M |
| Profits Per Employee | 8.09M |
| Employee Count | 572 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:543913 has paid 2.51 billion in taxes.
| Income Tax | 2.51B |
| Effective Tax Rate | 35.13% |
Stock Price Statistics
The stock price has increased by +1.40% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +1.40% |
| 50-Day Moving Average | 143.01 |
| 200-Day Moving Average | 137.46 |
| Relative Strength Index (RSI) | 65.84 |
| Average Volume (20 Days) | 17,367 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543913 had revenue of INR 24.20 billion and earned 4.63 billion in profits. Earnings per share was 3.05.
| Revenue | 24.20B |
| Gross Profit | 20.14B |
| Operating Income | 10.85B |
| Pretax Income | 7.13B |
| Net Income | 4.63B |
| EBITDA | 16.70B |
| EBIT | 10.85B |
| Earnings Per Share (EPS) | 3.05 |
Balance Sheet
The company has 11.33 billion in cash and 53.36 billion in debt, giving a net cash position of -42.03 billion.
| Cash & Cash Equivalents | 11.33B |
| Total Debt | 53.36B |
| Net Cash | -42.03B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 141.39B |
| Book Value Per Share | 93.32 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 83.22%, with operating and profit margins of 44.84% and 19.13%.
| Gross Margin | 83.22% |
| Operating Margin | 44.84% |
| Pretax Margin | 29.48% |
| Profit Margin | 19.13% |
| EBITDA Margin | 69.01% |
| EBIT Margin | 44.84% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 8.43, which amounts to a dividend yield of 5.61%.
| Dividend Per Share | 8.43 |
| Dividend Yield | 5.61% |
| Dividend Growth (YoY) | -8.52% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | 0.06% |
| Shareholder Yield | 5.67% |
| Earnings Yield | 2.03% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |